Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PNC-27
Cancer Research
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 32
Back to Home

Kisspeptin

Kisspeptin-54 / Kisspeptin-10

Kisspeptin is a neuropeptide encoded by the KISS1 gene that plays a critical role in regulating the hypothalamic-pituitary-gonadal (HPG) axis. It stimulates gonadotropin-releasing hormone (GnRH) secretion by binding to the GPR54/Kiss1R receptor, making it essential for reproductive function, puberty onset, and fertility. Originally discovered as a metastasis suppressor in certain cancers, kisspeptin has emerged as a promising therapeutic target for reproductive disorders including infertility, hypothalamic amenorrhea, and hypoactive sexual desire disorder.

Kisspeptin Dosing Guide

Primary Benefits

  • Stimulates natural gonadotropin-releasing hormone (GnRH) production
  • Increases luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels
  • Effective alternative to hCG for IVF ovulation induction with 23% pregnancy rate
  • Improves reproductive function in hypothalamic amenorrhea
  • Modulates sexual brain processing in hypoactive sexual desire disorder

How It Works

Kisspeptin exerts its effects by binding with high affinity to the G-protein coupled receptor GPR54 (also known as Kiss1R), which is predominantly expressed on GnRH neurons in the hypothalamus. Upon binding, it activates the Gq/11 signaling pathway, leading to increased intracellular calcium levels and phospholipase C activation. This cascade stimulates GnRH neurons to release GnRH into the hypothalamic-pituitary portal system, which subsequently binds to GnRH receptors on gonadotroph cells in the anterior pituitary. The result is pulsatile release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which regulate gonadal steroidogenesis and gametogenesis. The kisspeptin/Kiss1R system serves as the master regulator of reproductive function and is essential for pubertal development and maintenance of fertility.

Molecular Weight5859.3 Da (Kisspeptin-54)
Half-Life28 minutes to 1.8 hours (Kisspeptin-54)

Quick Reference

Typical Dosage Range

Kisspeptin dosing protocols vary significantly based on the specific clinical application and desired outcome. For IVF ovulation induction, single subcutaneous doses of kisspeptin-54 range from 1.6 nmol/kg (minimal effective dose) to 12.8 nmol/kg (optimal efficacy dose), administered 36 hours after final gonadotropin injection. For hypothalamic amenorrhea treatment, the established protocol uses 6.4 nmol/kg subcutaneously twice weekly for 8 weeks, with monitoring of LH and FSH levels. In research settings for male subjects, kisspeptin-10 doses from 0.03-3.0 μg/kg intravenously have been used to assess HPG axis responsiveness. For hypoactive sexual desire disorder studies, continuous intravenous infusion at 1 nmol/kg/h for 75 minutes has been employed. Chronic administration requires careful monitoring due to potential receptor desensitization and tachyphylaxis, necessitating dose holidays or pulsatile protocols to maintain efficacy.

Administration Methods

Kisspeptin administration requires careful attention to route, timing, and preparation to ensure optimal bioavailability and efficacy. For subcutaneous injection (most common clinical route), kisspeptin-54 is reconstituted in sterile saline or water for injection at concentrations of 1-2 mg/mL, administered via 25-27 gauge needle into the abdominal subcutaneous tissue. Injection sites should be rotated to prevent local irritation. For intravenous administration, kisspeptin is diluted in normal saline and given as either bolus injection (over 1-2 minutes) or continuous infusion (typically 75 minutes for research protocols). The peptide should be protected from light and used within 24 hours of reconstitution. Pre-medication with antihistamines is not routinely required but may be considered in patients with known allergies. Monitoring of vital signs is recommended during initial administration, particularly with intravenous routes.

What It's Used For

Kisspeptin-10 is a master reproductive hormone regulator that stimulates the hypothalamic-pituitary-gonadal (HPG) axis. It acts upstream to trigger natural hormone cascades, making it essential for fertility and hormonal balance.

Male Fertility Enhancement

Increases LH and FSH to boost testosterone and sperm production naturally

Female Fertility Support

Helps trigger ovulation and regulates menstrual cycles in women with hormonal imbalances

TRT Support

Prevents testicular atrophy and maintains fertility during TRT by preserving natural hormone signaling

Sexual Enhancement

Enhances libido and sexual brain processing in both men and women

IVF & Assisted Reproduction

Safer alternative to hCG for triggering egg maturation with lower risk of ovarian hyperstimulation

How Much to Take

For Fertility

100-200 mcg every 3 days

Pulse dosing prevents receptor desensitization and maintains natural hormone rhythms

For TRT Support

50-100 mcg twice weekly

Maintains testicular function and natural hormone production during testosterone therapy

For Libido Enhancement

50 mcg every 3 days

Lower doses for sexual enhancement, effects occur within 2-4 hours of injection

Frequency

Every 2-3 days for pulse dosing. Avoid daily dosing to prevent receptor desensitization.

Timing

Morning injections align with natural hormone rhythms. For sexual enhancement, inject 2-3 hours prior.

Adjustment

Start with lower doses and monitor hormone response. Adjust based on lab results and symptoms.

How Long to Use It

Recommended Cycle Length

Use for 4-6 weeks, followed by a break of 2-4 weeks. Maximum duration: avoid continuous use beyond 8 weeks without breaks.

First results: Hormone changes within 24-48 hours. Sexual and fertility benefits typically seen after 2-3 weeks of consistent use.

Critical Timing Guidelines

  • Never use daily for extended periods - causes receptor desensitization
  • Take regular breaks to maintain effectiveness and reset sensitivity
  • Women should time based on menstrual cycle - most effective during preovulatory phase
  • If effects diminish, take a 2-4 week break to restore responsiveness

Need-to-Know Information

How It Works

Binds to KISS1R receptors in the hypothalamus and stimulates GnRH neurons to release gonadotropin-releasing hormone. This triggers a natural cascade of LH and FSH from the pituitary, maintaining the body's natural feedback loops unlike direct hormone replacement.

Key Benefits

  • Natural Stimulation: Works with your body's existing systems, not against them
  • No Cortisol/Prolactin Effects: Unlike older peptides, doesn't affect stress hormones
  • Preserves Fertility: Ideal for men on TRT who want to maintain fertility
  • Gender-Specific Response: Effects vary based on menstrual cycle phase in women

Who Should Avoid It

  • Pregnant or breastfeeding women
  • Those with hormone-sensitive cancers
  • People with active pituitary tumors
  • Women during follicular phase (less responsive)

Possible Side Effects

  • Injection site irritation
  • Temporary flushing or warmth
  • Mild headache
  • Potential hormone fluctuations if overdosed

Storage & Injection

Mixing Instructions

Use bacteriostatic water to reconstitute the peptide.

Example: Add 2 mL of bacteriostatic water to a 5 mg vial. For a 100 mcg dose, draw 0.04 mL (4 units on insulin syringe).

Storage Requirements

Store mixed vials in the fridge at 2-8°C (36-46°F).

Use within 30 days after reconstitution. Protect from light and avoid shaking.

Injection Sites

  • Belly fat (most common)
  • Upper thigh
  • Buttocks area

Method

Subcutaneous (under the skin). Clean site with alcohol, pinch skin, insert at 45-degree angle.

Tips

Inject slowly, rotate sites, time injections based on your protocol (not daily).

Example Schedule

Weekly Dosing Schedules

Male Fertility Protocol

Monday: 200 mcg injection
Thursday: 200 mcg injection
Continue for 4-6 weeks, then 2-week break

Female Fertility Protocol

Day 10-12: 100 mcg injection
Day 13-14: 150 mcg injection
Monitor ovulation and adjust timing

TRT Support Protocol

Tuesday: 100 mcg injection
Friday: 100 mcg injection
Continue throughout TRT cycle

Missed Dose Guidelines

If you miss a dose, take it as soon as you remember, but maintain the 2-3 day spacing between injections. Do not double dose to make up for missed injections. Since kisspeptin works on pulse dosing, missing one injection won't significantly impact your overall progress.

Extra Tips for Best Results

Timing is Everything

Pulse dosing (every 2-3 days) is more effective than daily dosing. Prevents receptor downregulation and maintains sensitivity.

Monitor Hormone Levels

Test LH, FSH, and testosterone/estrogen before starting. Retest after 4 weeks to assess response and adjust dosing.

For Male Fertility

Combine with lifestyle changes: reduce heat exposure to testicles, maintain healthy weight, exercise regularly, consider zinc and vitamin D supplementation.

For Female Fertility

Most effective during preovulatory phase (days 10-14). Less responsive during follicular phase. Track ovulation with basal body temperature.

Expected Timeline

24-48 Hours

Initial hormone changes detectable in blood work

Week 2-3

Sexual and fertility benefits become noticeable

Week 4-6

Peak fertility and hormone optimization effects

Important Reminders

  • Research compound only - Not FDA-approved for human therapeutic use
  • Avoid receptor fatigue - Never use daily for extended periods without breaks
  • Monitor hormone levels - Regular blood work is essential for safe use
  • Gender-specific timing - Women should coordinate with menstrual cycle phases
  • Consider medical supervision - Especially important for fertility applications

Medical Disclaimer

Kisspeptin is in Phase 2 clinical trials for reproductive applications. This information is for educational purposes only and should not be construed as medical advice. Any clinical use should occur only under medical supervision in approved research or clinical settings.